Original Research
Accepted on 25 Nov 2024
Immunogenicity and safety of the fourth dose of quadrivalent human papillomavirus (HPV) vaccine in immunosuppressed women who did not seroconvert after three doses
in Virus and Host
Original Research
Accepted on 25 Nov 2024
in Virus and Host
Original Research
Accepted on 25 Nov 2024
in Virus and Host
Original Research
Accepted on 22 Nov 2024
in Virus and Host
Review
Published on 22 Nov 2024
in Virus and Host
Original Research
Published on 22 Nov 2024
in Virus and Host
Review
Accepted on 19 Nov 2024
in Virus and Host
Original Research
Published on 19 Nov 2024
in Virus and Host
Original Research
Published on 18 Nov 2024
in Virus and Host
Original Research
Accepted on 14 Nov 2024
in Virus and Host
Original Research
Accepted on 13 Nov 2024
in Virus and Host
Review
Accepted on 08 Nov 2024
in Virus and Host
Original Research
Published on 08 Nov 2024
in Virus and Host
Original Research
Published on 06 Nov 2024
in Virus and Host
Original Research
Accepted on 05 Nov 2024
in Virus and Host
Original Research
Published on 04 Nov 2024
in Virus and Host
Original Research
Published on 04 Nov 2024
in Virus and Host